For example, a positive family history of breast cancer and genes such as BRCA1/2, important risk factors for breast cancer, may motivate the selection of a prolactin-sparing antipsychotic, although there was limited evidence of this potential association available during the study period, reducing the likelihood that it would have had an important effect on the results. The gene discussed is BRCA1; the disease is breast cancer.